Stock detail
Enliven Therapeutics (ELVN) stock price, chart, and key data
View Enliven Therapeutics stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
Enliven Therapeutics
ELVN · XNAS
$54.36
-3.33%
-$1.87
Key metrics
52-week range
$4.75 - $0.00
Close price
$56.23
Market cap
$4.2B
P/E ratio
-87.91
Beta
0.51
About the company
Enliven Therapeutics Inc
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
Analyst rating summary
A current read on analyst sentiment from the insight feed.
Mean target
$72.55
13
Buy
/ 13
Recent calls
08/22/2026
William Blair
Andy Hsieh
Buy
08/18/2026
Barclays
Etzer Darout
Buy · Price target $78.00
08/17/2026
Mizuho Securities
Salim Syed
Buy · Price target $73.00
Ticker holders
Review politician disclosures and insider transactions in tabs.
No holder data is available for this category yet.
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app